ArticleHuman vaccines & immunotherapeutics2018

Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells.

Chutamas Thepmalee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.